8GI1
Homo-octamer of PbuCsx28 protein
Summary for 8GI1
| Entry DOI | 10.2210/pdb8gi1/pdb |
| EMDB information | 40059 |
| Descriptor | Accessory protein Csx28 (1 entity in total) |
| Functional Keywords | crispr-associated protein, antiviral protein |
| Biological source | Prevotella buccae |
| Total number of polymer chains | 8 |
| Total formula weight | 175281.54 |
| Authors | Park, J.U.,Kellogg, E.H. (deposition date: 2023-03-13, release date: 2023-04-26, Last modification date: 2024-06-19) |
| Primary citation | VanderWal, A.R.,Park, J.U.,Polevoda, B.,Nicosia, J.K.,Molina Vargas, A.M.,Kellogg, E.H.,O'Connell, M.R. Csx28 is a membrane pore that enhances CRISPR-Cas13b-dependent antiphage defense. Science, 380:410-415, 2023 Cited by PubMed Abstract: Type VI CRISPR-Cas systems use RNA-guided ribonuclease (RNase) Cas13 to defend bacteria against viruses, and some of these systems encode putative membrane proteins that have unclear roles in Cas13-mediated defense. We show that Csx28, of type VI-B2 systems, is a transmembrane protein that assists to slow cellular metabolism upon viral infection, increasing antiviral defense. High-resolution cryo-electron microscopy reveals that Csx28 forms an octameric pore-like structure. These Csx28 pores localize to the inner membrane in vivo. Csx28's antiviral activity in vivo requires sequence-specific cleavage of viral messenger RNAs by Cas13b, which subsequently results in membrane depolarization, slowed metabolism, and inhibition of sustained viral infection. Our work suggests a mechanism by which Csx28 acts as a downstream, Cas13b-dependent effector protein that uses membrane perturbation as an antiviral defense strategy. PubMed: 37104586DOI: 10.1126/science.abm1184 PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (3.65 Å) |
Structure validation
Download full validation report






